Skip to main content

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Partners with Solera Health for Added Hypertension Management Solutions

DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, is partnering with Solera Health to offer a world-class solution for treating hypertension. Solera Health is a premier platform for connecting people to proven, personalized health solutions, and this new partnership expands Solera’s suite of best-in-class digital and community evidence-based health solutions. The new partnership will create a turnkey hypertension management solution available for payers’ and employers’ member populations that requires just one contract and one technical integration; the collaboration also offers users with intersectional conditions a way to take a more comprehensive approach to managing their health. According to the announcement, Dario’s hypertension solution combines a Bluetooth or cellular-connected blood pressure monitor; a smart app that provides tracking, feedback and user specific content; and specially trained health coaches to provide one-on-one support.  Elements of the program include rewards and gamification to maintain engagement as well as the ability to add blood glucose, weight, diet and activity data. The platform creates a “hyper-personalized” experience. “We are excited to partner with Solera and share our digital hypertension solutions with their payer and employer clients,” said DarioHealth president and general manager of North America Rick Anderson in the press release. “Dario is committed to improving access and quality of care for individuals with hypertension by expanding the reach of our highly personalized solutions. This collaboration with Solera expands our ability to reach patients and continue our mission of transforming care for people with chronic conditions.”

To view the full press releases, visit https://ibn.fm/21aGp and https://ibn.fm/iO5ie

About DarioHealth Corp.

DarioHealth is a leading digital therapeutics (“DTx”) company revolutionizing how people with chronic conditions manage their health through a user-centric, multichronic condition platform. The company’s platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain and behavioral health. DRIO’s user-centric platform offers people continuous and customized care for health, disrupting the traditional episodic approach to healthcare. This approach empowers people to holistically adapt their lifestyles for sustainable behavior change, driving exceptional user satisfaction, retention, and results. Dario provides its highly user rated solutions globally to health plans and other payors, self-insured employers, providers of care and directly to consumers. For more information about the company, please visit www.DarioHealth.com.

NOTE TO INVESTORS: The latest news and updates relating to DRIO are available in the company’s newsroom at http://ibn.fm/DRIO

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.